SMTL ID : 9fmm.1 (1 other biounit)

Structure of human ACE2 in complex with a fluorinated small molecule inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 01: (2~{S})-2-[[(2~{S})-3-[3-[(3-chloranyl-5-fluoranyl-phenyl)methyl]imidazol-4-yl]-1-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-4-methyl-pentanoic acid

01.1: 19 residues within 4Å: Chain A: R.255, F.256, H.327, P.328, T.329, D.349, D.350, T.353, H.356, E.357, H.360, E.384, F.486, H.487, Y.492, R.496, Y.497 Ligands: EDO.4, ZN.12 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:P.328, A:P.328, A:F.486, A:Y.492 Hydrogen bonds: A:H.327, A:Y.497 Salt bridges: A:R.255, A:H.327, A:H.356, A:H.360, A:H.487 Halogen bonds: A:D.350

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 5 residues within 4Å: Chain A: N.35, T.37, E.39, N.40, Q.322 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.35, A:E.39, A:N.40 NAG.3: 4 residues within 4Å: Chain A: N.141, N.672, S.674, D.675 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.141, A:D.675 NAG.5: 4 residues within 4Å: Chain A: F.267, N.414, E.415, W.576 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:E.415

5 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 5 residues within 4Å: Chain A: L.352, T.353, E.388, S.391 Ligands: 01.1 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:L.352, A:S.391 EDO.6: 3 residues within 4Å: Chain A: E.220, G.587, W.588 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.220, A:W.588, A:W.588 Water bridges: A:E.220 EDO.7: 5 residues within 4Å: Chain A: F.22, S.26, A.330, W.331, D.332 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.26, A:D.332 EDO.8: 7 residues within 4Å: Chain A: A.135, S.137, L.138, R.143, N.259, L.260, S.262 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.262, A:S.262 EDO.9: 5 residues within 4Å: Chain A: W.185, E.380, Y.492, S.493, R.496 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.380, A:S.493, A:S.493, A:R.496

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.10: 3 residues within 4Å: Chain A: L.125, P.128, G.129 Ligand excluded by PLIP

1 x NA: SODIUM ION(Non-functional Binders)

NA.11: 7 residues within 4Å: Chain A: M.134, R.143, A.246, H.247, L.248, L.249, D.251 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.143, A:H.247, A:L.249

1 x ZN: ZINC ION(Non-covalent)

ZN.12: 4 residues within 4Å: Chain A: H.356, H.360, E.384 Ligands: 01.1 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.356, A:H.360, A:E.384

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, J. et al., Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2. Eur J Nucl Med Mol Imaging (2024)

Release Date

2024-07-17

Peptides

Angiotensin-converting enzyme 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Angiotensin-converting enzyme 2

Related Entries With Identical Sequence